Atbin Djamshidian

Medical University of Innsbruck

Austria

Research Interests

Explore related searches

Professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (4)

Wolfgang Löscher

Medical University of Innsbruck

AUSTRIA

View details

Margarete Delazer

ao.Prof.

Medical University of Innsbruck

AUSTRIA

View details

Andrew John Lees

University College London

UNITED KINGDOM

View details

Markus Schuelke

Professor

Charité - Universitätsmedizin Berlin

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Atbin Djamshidian

Research Interests

Explore related searches

Contact this professor

Articles (14)

Preferences regarding Disclosure of Risk for Parkinson's Disease in a Population‐based Study

Neuropsychiatric disorders in Parkinson’s disease

Objective and subjective cognitive outcomes one year after COVID‐19

Impulse Control Disorders in Parkinson’s Disease: An Overview of Risk Factors, Pathogenesis and Pharmacological Management

Effects of Nabilone on Sleep Outcomes in Patients with Parkinson's Disease: A Post‐hoc Analysis of NMS‐Nab Study

Neurological outcomes 1 year after COVID‐19 diagnosis: A prospective longitudinal cohort study

Cardiac sympathetic innervation in Parkinson’s disease versus multiple system atrophy

Factors associated with augmentation in patients with restless legs syndrome

Synonymous mutation in adenosine triphosphatase copper‐transporting beta causes enhanced exon skipping in Wilson disease

Differentiating Parkinson’s Disease from Essential Tremor Using Transcranial Sonography: A Systematic Review and Meta-Analysis

Neuropsychiatric Features of Punding and Hobbyism in Parkinson's Disease

The prevalence of impulsive compulsive behaviors in patients treated with apomorphine infusion: a retrospective analysis

Factors associated with impaired quality of life three months after being diagnosed with COVID-19

Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson’s Disease: A Randomized, Placebo-Controlled, Phase 1 Study

Collaborators (4)

Wolfgang Löscher

Margarete Delazer

Andrew John Lees

Markus Schuelke

Make your next move.